iosBio
PrivateLast Round
Series A
May 1, 2025
Total Funding Raised
$390,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iosBio operates in Healthcare & Life Sciences and is based in Haywards Heath. Its latest recorded funding round was a Grant round in February 2022.
iosBio is a biotechnology company that develops thermostable, orally delivered vaccines for major infectious diseases using its proprietary OraPro™ and Enhanced Surface Display (ESD™) technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iosBio Comparables
Compare iosBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GIVAX | 78% | |
| Vaxart, Inc. | 78% | |
| Esperovax | 76% |
For institutional investors. Book with your work email.
iosBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2025 | ||||
| Grant | Feb 23, 2022 | ||||
| VC Round | May 12, 2020 | ||||
| VC Round | Mar 18, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
iosBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shackleton Ventures | VC Round |
| Department of Health and Social Care | Grant |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 122% MoM.
- Jul 25, 2026
Monthly visitors increased 116% MoM.
For institutional investors. Book with your work email.
iosBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iosBio's valuation, stock price, and market status.
Is iosBio a public or private company?
iosBio is a private company.
What is the current stock price of iosBio?
iosBio is a private company, so its shares have no public market price. Caplight tracks iosBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iosBio worth (valuation)?
Valuation information for iosBio is not publicly available.
Can I buy iosBio stock?
iosBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iosBio's last funding round?
iosBio's most recent funding round was Series A on May 1, 2025.
Who are the main investors in iosBio?
Key investors in iosBio include Shackleton Ventures, Department of Health and Social Care, Innovate UK.
Will iosBio IPO soon?
No public IPO plans have been announced for iosBio.
How can I track iosBio secondary market activity?
Caplight tracks bids, offers, and trades in iosBio's shares on secondary markets.